MMLV reverse transcriptase variants
Assignee
10X GENOMICS, INC.
Inventors
Josephine Lee, Samuel Marrs, Geoffrey McDermott, Francesca Meschi, Luz Montesclaros, Katherine Pfeiffer, Joseph Francis Shuga, Jessica Michele Terry, Solongo B. Ziraldo
Abstract
Disclosed herein, are compositions, methods, and kits comprising engineered reverse transcription enzymes that exhibit several desired properties such as thermal stability, processive reverse transcription, non-templated base addition, and template switching ability. The engineered reverse transcription enzymes described herein demonstrate unexpectedly higher resistance to cell lysate inhibition, greater ability to capture full-length mRNA transcripts, and demonstrate improved results in small reaction volumes as compared to other engineered reverse transcription enzymes.
CPC Classifications
Filing Date
2020-12-07
Application No.
17114016
Claims
10